Search Results - "Wynn, DR"

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis by Rudick, Richard A, Stuart, William H, Calabresi, Peter A, Confavreux, Christian, Galetta, Steven L, Radue, Ernst-Wilhelm, Lublin, Fred D, Weinstock-Guttman, Bianca, Wynn, Daniel R, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…In this randomized trial involving patients with relapsing multiple sclerosis who had had relapses despite treatment with interferon, natalizumab in…”
Get full text

The incidence and significance of anti-natalizumab antibodies : Results from AFFIRM and SENTINEL by CALABRESI, P. A, GIOVANNONI, G, POLMAN, C. H, RADUE, E.-W, RUDICK, R. A, STUART, W. H, LUBLIN, F. D, WAJGT, A, WEINSTOCK-GUTTMAN, B, WYNN, D. R, LYNN, F, PANZARA, M. A, CONFAVREUX, C, GALETTA, S. L, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, MILLER, D. H, O'CONNOR, P. W, PHILLIPS, J. T

“…To determine the incidence and clinical effects of antibodies that develop during treatment with natalizumab. In two randomized, double-blind,…”
Get full text

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL by Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.

“…The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNβ)-1a in patients with…”
Get full text

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials by Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

“…Background: In Phase 3 double-blind trials (MS-F203 and MS-F204), dalfampridine extended release tablets 10 mg twice daily (dalfampridine-ER; prolonged-release…”
Get full text

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis by Panitch, Hillel S., Thisted, Ronald A., Smith, Richard A., Wynn, Daniel R., Wymer, James P., Achiron, Anat, Vollmer, Timothy L., Mandler, Raul N., Dietrich, Dennis W., Fletcher, Malcolm, Pope, Laura E., Berg, James E., Miller, Ariel

“…Objective To evaluate the efficacy and safety of DM/Q (capsules containing dextromethorphan [DM] and quinidine [Q]) compared with placebo, taken twice daily,…”
Get full text

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota by WYNN, D. R, RODRIGUEZ, M, O'FALLON, W. M, KURLAND, L. T

“…A review of multiple sclerosis (MS) case reports, using the unified record system at the Mayo Clinic for the Olmsted County population, revealed age- and…”
Get full text

Update on the epidemiology of multiple sclerosis by Wynn, D R, Rodriguez, M, O'Fallon, W M, Kurland, L T

“…Neuroepidemiology has been important in providing clues about the cause and pathogenesis of multiple sclerosis. In this review, we update the incidence and…”
Get more information

Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls by RODRIGUEZ, M, WYNN, D. R, KIMLINGER, T. K, KATZMANN, J. A

“…We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We…”
Get full text

A physical sign of bulimia by Wynn, D R, Martin, M J

Get more information

Staff Utilization, Development, and Evaluation by Wynn, D. Richard, De Remer, Richard W.

Get full text